Q-IVF, 2016

Q-IVF Annual Report 2016: Fertility Treatments in Sweden (Treatment Year 2014)

Q-IVF, National Quality Registry for Assisted Reproduction

Read at source

Key figures

Treatment volume, 2014

Measure Value Source
Number of IVF clinics active in Sweden during 2014 16 Introduction
Number of those clinics that were publicly run, 2014 6 Introduction
Number of those clinics that were privately run, 2014 10 Introduction
Share of Swedish IVF clinics submitting complete data to the registry, 2014 100% Introduction
IVF cycles begun using the patient's own eggs and sperm, Sweden, 2014 18,035 Figure 1 text
Fresh cycles begun at Linnekliniken in Uppsala, Sweden's busiest clinic, 2014 1112 Figure 1
Fresh cycles begun at RMC Malmo, the clinic that started the most fresh cycles nationally, 2014 1097 Figure 1
Share of Swedish IVF patients under age 38, 2014 Over 70% Figure 3
Share of Swedish IVF patients falling in the 30 to 34 age band, the largest cohort, 2014 33.69% Figure 3
Fresh IVF/ICSI cycles with own gametes begun for patients aged 30 to 34, Sweden, 2014 3895 Figure 4

Outcomes, 2014

Measure Value Source
Share of started fresh cycles reaching clinical pregnancy, patients aged 25-29, Sweden, 2014 33% Figure 7
Share of started fresh cycles ending in a delivery, patients aged 25-29, the top result among age bands, Sweden, 2014 29% Figure 8
Share of started fresh cycles ending in a delivery, patients aged 30-34, Sweden, 2014 25% Figure 8
Share of started fresh cycles ending in a delivery, patients aged 35-37, Sweden, 2014 22% Figure 8
Share of started fresh cycles ending in a delivery, patients aged 38-39, Sweden, 2014 16% Figure 8
Share of started fresh cycles ending in a delivery, patients aged 40-41, Sweden, 2014 10% Figure 8
Share of started fresh cycles ending in a delivery, patients over age 41, Sweden, 2014 5% Figure 8

Embryo transfer practice, 2014

Measure Value Source
Share of fresh embryo transfers using a single embryo, Sweden, 2014 80% Figure 6
Share of frozen embryo transfers using a single embryo, Sweden, 2014 94% Figure 6
Share of fresh own-gamete transfers performed on culture day 2 or 3, patients under 31, Sweden, 2014 82% Figure 5
Share of fresh own-gamete transfers performed as day 5 or 6 blastocysts, patients under 31, Sweden, 2014 18% Figure 5
Share of frozen-cycle own-gamete transfers performed on culture day 2 or 3, patients under 31, Sweden, 2014 43% Figure 5
Share of frozen-cycle own-gamete transfers performed as day 5 or 6 blastocysts, patients under 31, Sweden, 2014 57% Figure 5

Donor treatment, 2014

Measure Value Source
Share of embryo transfers using donor eggs that ended in delivery, fresh cycles, Sweden, 2014 28% Figure 12
Share of embryo transfers using donor eggs that ended in delivery, frozen cycles, Sweden, 2014 20% Figure 12
Share of embryo transfers using donor sperm that ended in delivery, fresh cycles, Sweden, 2014 34% Figure 12
Share of embryo transfers using donor sperm that ended in delivery, frozen cycles, Sweden, 2014 29% Figure 12
Share of donor insemination (AID) cycles ending in delivery, Sweden, 2014 16% Figure 12

Multiple births, 2014

Measure Value Source
Overall multiple birth rate following fresh IVF cycles, Sweden, 2014, first time under 5% 4.7% Comment below Figure 10
Overall multiple birth rate following frozen embryo transfer cycles, Sweden, 2014 3.0% Comment below Figure 10
Share of fresh IVF/ICSI deliveries with own gametes that were twins, patients aged 35-37 (peak age band), Sweden, 2014 6.5% Figure 9
Share of fresh IVF/ICSI deliveries with own gametes that were triplets, patients aged 35-37, Sweden, 2014 0.0% Figure 9
Share of frozen IVF/ICSI deliveries with own gametes that were twins, patients aged 40-41 (peak age band), Sweden, 2014 7.0% Figure 10
Share of frozen IVF/ICSI deliveries with own gametes that were triplets, patients aged 40-41, Sweden, 2014 0.0% Figure 10

Live births, 2014

Measure Value Source
Children born as a result of IVF treatment, Sweden, 2014 4,341 Summary box
Share of all Swedish births in 2014 that were IVF-conceived 3.8% Summary

Trends

Measure Value Source
Assisted-reproduction treatments logged cumulatively in the Q-IVF registry since it launched in 2007, through 2014 more than 140,000 Section 4

Patient experience

Measure Value Source
Patients responding to the 2015 IVF-KUPP satisfaction survey, Sweden 2,905 Figure 18

Background

Measure Value Source
Couples in Sweden estimated to face involuntary childlessness (background estimate) 10-15 percent Section 3 (Background)

Our summary of the report's published figures, each citing its table, figure or section. The full report is at the publisher's link.

Topics

Q-IVF et al. 2016, Q-IVF 2016

Related articles